IPCHS. Integrated People-Centred Health Services

Practices

 
Sept. 22, 2016 Leading practice Europe

Establishing ambulatory care for patients with tuberculosis in Uzbekistan

Summary

Médecins Sans Frontières (MSF), in partnership with the Government of the Republic of Karakalpakstan, introduced ambulatory care from day one (ACD1) as an alternative model for TB care; a strong understanding of service delivery challenges led to a solution that met patients’ needs; a supportive political and legal framework, developed prior to implementation, helped to sustainably embed reforms within the health system; strong relationships between key actors who had a history of working together aided the initiative.

Description of practice
City: Karakalpakstan Country: Uzbekistan
The problem

Throughout the early 2000s, tuberculosis (TB) became a growing public health concern in Uzbekistan and rates of multidrug-resistant tuberculosis (MDR-TB) increased. MDR-TB was estimated to account for 23% of newly diagnosed TB cases and 62% of retreatment cases between 2010 and 2011. Longer treatment periods required for the management of MDR-TB (at least eight months), combined with the high number of individuals requiring care, called into question the existing treatment model requiring hospitalization for all patients during the intensive phase. The continued use of a consilium model, whereby a single group of specialists made every TB treatment decision, caused further delays. Patients waiting for treatment risked transmitting the disease to the population and a lack of segregation between drug-sensitive and drug-resistant hospitalized patients risked cross-contamination of TB strains.

The solution

In the autonomous north-western region of Karakalpakstan, a new TB care model was introduced by the Government of the Republic of Karakalpakstan, in partnership with Médecins Sans Frontières (MSF), to provide a comprehensive TB treatment strategy based on ambulatory care from day one (ACD1). ACD1 enables patients to start TB treatment in ambulatory settings, avoiding the need for hospitalization. Initially piloted in two of Karakalpakstan’s 16 districts, the initiative has since been expanded across Karakalpakstan. System-wide changes, including a new legal framework and the decentralization of decision-making structures, have accompanied the initiative to allow for locally-tailored service delivery. Extensive training for providers was carried out to allow task shifting from TB specialists in hospital settings to generalist providers at the community level. TB treatment guidelines and protocols have been simplified to facilitate their appropriate use by non-TB specialists. Investments in complementary infrastructure and resources have ensured that local health facilities are adequately equipped to safely deliver care, and rapid diagnostic technology has been introduced.

Implementation of practice
What stage is the practice currently in?

Fully implemented and scaled up

Who was/is responsible for the implementation of the practice?

MSF developed the Comprehensive Care for All TB treatment strategy and advocated for its introduction. The strong working relationship MSF had from collaborations with the Ministry of Health of the Republic of Karakalpakstan on other TB programmes in the region helped to secure government support for this initiative. As TB was a high government priority, the Ministry was a willing and active partner. While the introduction and early management of the initiative was led by MSF, the Ministry played a critical role in establishing necessary political and legal frameworks. A gradual handover of responsibilities from MSF to the Ministry has begun and it is expected that the Ministry will assume full responsibility over comprehensive TB programmes by 2017.  

Impact

Only preliminary data on the impact of treatment with ACD1 is available as the number of patients who have completed treatment is still modest. Early outcomes are positive and suggest the initiative is performing at least as well as the previous treatment model. The proportion of patients receiving ACD1 has been steadily increasing over time. In 2012, approximately half of the 1420 patients who started TB treatment received ACD1. Median time between diagnostic sputum collection and treatment initiation fell from six weeks prior to the initiative to less than two weeks in 2015, indicating that ACD1 enables patients to start treatment sooner. Patients receiving ACD1 have also shown better adherence to prescribed drug regimens during the post-intensive treatment phase. 

Additional information

This case was prepared as part of a larger effort by the WHO Regional Office for Europe and published (2016) in the document, "Lessons from transforming health services delivery: Compendium of initiatives in the WHO European Region".

© Copyright World Health Organization (WHO), 2016

The methodology used for the development of this case is slightly different from the templates used on the IntegratedCare4People web platform, in particular in the analysis of enabling factors and barriers to change.

 

Please click on the link below for more information about this practice. 

Contact information
Name:
Sebastian Dietrich
Organization:
Médecins Sans Frontières (MSF)
Email:
info@integratedcare4people.org
Phone:
Role:
None
Comments
 

Andrew Naomi 17/04/2022 02:16

I was infected with Herpes (HSV) two years ago and I was devastated. I visited different hospitals but they only gave me drugs to treat the symptoms. One day I was browsing through Dr. SEBI then I found a lady who introduced me to an Herbal Doctor called Dr. OJAMO. She explained to me how Dr. OJAMO cured her from herpes with natural herbs and root products, she gave me the doctor Email:: dr.ojamoherbalhome@gmail. com I contacted him and asked him questions about his product. He explained to me how the product works and also showed me those he has cured with his product. He told me he would prepare the product and shipped it to me, the product got delivered after 5 days of delivery. I took the product as instructed by Dr. OJAMO and after 21 days I was having diarrhea and constantly urinating. I went for a test and I was tested for Herpes Negative. The product worked exactly the way Dr. OJAMO instructed and now I am free from HSV. I am very happy, I will recommend this great testimony to save a lot of people suffering from Herpes. Contact: Dr. OJAMO Whats-app:: https://wa.me/2349077406037 also Email dr.ojamoherbalhome@gmail.com His website https://drojamoherbalhome.wixsite.com/welcometodrojamoherb

Monica Raymond 18/04/2022 09:43

One day I was reading an article online we’re I found about Dr. Ojamo and how people have been cured using his herbs and roots so I message Dr. Ojamo on WhatsApp  https://wa.me/2349077406037   and I got a reply. He told me with God everything is possible. Dr. Ojamo told me about plants/herbs and it’s purpose that when he told me no matter the situation you found yourself in there is always a solution. I decided to try Dr. Ojamo Healing Herbs. He made a fresh herb and told me the plant and root because his product is 100% plants and root cooked and packaged inside a container and he shipped it through UPS. I received it and finished the product exactly 21 days ago and before then I was having diabetes and difficulties in breathing, I went to the hospital and my doctor was surprised how I got cured from all these diseases then I said praise to God .  Share Dr. Ojamo email: dr.ojamoherbalhome@gmail.com or you can call and WhAtsapp him on  https://wa.me/2349077406037   if you are infected with HERPES virus or having any health problems contact Dr. Ojamo and he will help you. Share his email so that everyone will know there are herbs and roots that cures every diseases because there can never be a smoke without a fire; dr.ojamoherbalhome@gmail.com   Check his Website https://drojamoherbalhome.wixsite.com/welcometodrojamoherb

Add your comment


Sign in to add your comment.